Study with us
Enterprise Competition Judge and postgraduate in Biotechnology (G08)
Dr Golnaz Borghei comes with broad expertise in building and growing early stage biotech/medtech companies: investment, fundraising and business development.
Golnaz has 15+ years research commercialisation experience; she received her PhD in biotechnology from the University of Cambridge, Churchill college, where her work on novel biosensors was published in the NATO Science for Peace and Security Book Series. Golnaz’ postdoctoral research at the universities of Cambridge and Oxford focused on development of novel CNS drugs. She has led multiple cross-border collaborations with leading companies and institutes such as Perkin Elmer and the US National Academy of Sciences.
Dr Borghei is an Executive MBA candidate at Frankfurt School of Finance and Management, and holds an executive Finance certificate from Harvard Business School. She is experienced in financial valuation of early-stage biotech projects through building business cases, market and competitor analysis, development plans and sales forecast. Golnaz is specialised in business development for early- to mid-stage companies and expanding strategic partnerships. Thus she is constantly involved in preparing business plans and presentations for fundraising through dilutive and non-dilutive sources.
Golnaz has also been advisor to family office investors in Europe and the UK on deal evaluations for heath-tech investment opportunities. She has been a jury member, lecturer and mentor for several life science accelerators, including Cambridge-based Innovation Forum and the Scandinavia Venture Cup.
Having lived and worked in the UK, Germany, Scandinavia and the Middle East, Golnaz has a broad global network in life science industry, and an international perspective on entrepreneurship and multi-disciplinary collaborations.